Global and United States Quadrivalent Flu Vaccine Market Report & Forecast 2023-2028

Report ID: 1788789 | Published Date: Jan 2025 | No. of Page: 94 | Base Year: 2024 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Quadrivalent Flu Vaccine Product Introduction
    1.2 Global Quadrivalent Flu Vaccine Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Quadrivalent Flu Vaccine Sales in US$ Million for the Year 2017-2028
        1.2.2 Global Quadrivalent Flu Vaccine Sales in Volume for the Year 2017-2028
    1.3 United States Quadrivalent Flu Vaccine Outlook 2017 VS 2022 VS 2028
        1.3.1 United States Quadrivalent Flu Vaccine Sales in US$ Million for the Year 2017-2028
        1.3.2 United States Quadrivalent Flu Vaccine Sales in Volume for the Year 2017-2028
    1.4 Quadrivalent Flu Vaccine Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.4.1 The Market Share of United States Quadrivalent Flu Vaccine in Global, 2017 VS 2022 VS 2028
        1.4.2 The Growth Rate of Quadrivalent Flu Vaccine Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.5 Quadrivalent Flu Vaccine Market Dynamics
        1.5.1 Quadrivalent Flu Vaccine Industry Trends
        1.5.2 Quadrivalent Flu Vaccine Market Drivers
        1.5.3 Quadrivalent Flu Vaccine Market Challenges
        1.5.4 Quadrivalent Flu Vaccine Market Restraints
    1.6 Study Objectives
    1.7 Years Considered
2 Market by Type
    2.1 Quadrivalent Flu Vaccine Market Segment by Type
        2.1.1 Intramuscular Injection
        2.1.2 Nasal Spray
        2.1.3 Intradermal Shot
    2.2 Global Quadrivalent Flu Vaccine Market Size by Type
        2.2.1 Global Quadrivalent Flu Vaccine Sales in Value, by Type (2017, 2022 & 2028)
        2.2.2 Global Quadrivalent Flu Vaccine Sales in Volume, by Type (2017, 2022 & 2028)
        2.2.3 Global Quadrivalent Flu Vaccine Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    2.3 United States Quadrivalent Flu Vaccine Market Size by Type
        2.3.1 United States Quadrivalent Flu Vaccine Sales in Value, by Type (2017, 2022 & 2028)
        2.3.2 United States Quadrivalent Flu Vaccine Sales in Volume, by Type (2017, 2022 & 2028)
        2.3.3 United States Quadrivalent Flu Vaccine Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
    3.1 Quadrivalent Flu Vaccine Market Segment by Application
        3.1.1 Hospital
        3.1.2 Clinic
        3.1.3 Public Health Agency
        3.1.4 Other
    3.2 Global Quadrivalent Flu Vaccine Market Size by Application
        3.2.1 Global Quadrivalent Flu Vaccine Sales in Value, by Application (2017, 2022 & 2028)
        3.2.2 Global Quadrivalent Flu Vaccine Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 Global Quadrivalent Flu Vaccine Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    3.3 United States Quadrivalent Flu Vaccine Market Size by Application
        3.3.1 United States Quadrivalent Flu Vaccine Sales in Value, by Application (2017, 2022 & 2028)
        3.3.2 United States Quadrivalent Flu Vaccine Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 United States Quadrivalent Flu Vaccine Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Quadrivalent Flu Vaccine Competitor Landscape by Company
    4.1 Global Quadrivalent Flu Vaccine Market Size by Company
        4.1.1 Top Global Quadrivalent Flu Vaccine Manufacturers Ranked by Revenue (2021)
        4.1.2 Global Quadrivalent Flu Vaccine Revenue by Manufacturer (2017-2022)
        4.1.3 Global Quadrivalent Flu Vaccine Sales by Manufacturer (2017-2022)
        4.1.4 Global Quadrivalent Flu Vaccine Price by Manufacturer (2017-2022)
    4.2 Global Quadrivalent Flu Vaccine Concentration Ratio (CR)
        4.2.1 Quadrivalent Flu Vaccine Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Quadrivalent Flu Vaccine in 2021
        4.2.3 Global Quadrivalent Flu Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Quadrivalent Flu Vaccine Manufacturing Base Distribution, Product Type
        4.3.1 Global Quadrivalent Flu Vaccine Manufacturers, Headquarters and Distribution of Producing Region
        4.3.2 Manufacturers Quadrivalent Flu Vaccine Product Type
        4.3.3 Date of International Manufacturers Enter into Quadrivalent Flu Vaccine Market
    4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    4.5 United States Quadrivalent Flu Vaccine Market Size by Company
        4.5.1 Top Quadrivalent Flu Vaccine Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Quadrivalent Flu Vaccine Revenue by Players (2020, 2021 & 2022)
        4.5.3 United States Quadrivalent Flu Vaccine Sales by Players (2020, 2021 & 2022)
5 Global Quadrivalent Flu Vaccine Market Size by Region
    5.1 Global Quadrivalent Flu Vaccine Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Quadrivalent Flu Vaccine Market Size in Volume by Region (2017-2028)
        5.2.1 Global Quadrivalent Flu Vaccine Sales in Volume by Region: 2017-2022
        5.2.2 Global Quadrivalent Flu Vaccine Sales in Volume Forecast by Region (2023-2028)
    5.3 Global Quadrivalent Flu Vaccine Market Size in Value by Region (2017-2028)
        5.3.1 Global Quadrivalent Flu Vaccine Sales in Value by Region: 2017-2022
        5.3.2 Global Quadrivalent Flu Vaccine Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Quadrivalent Flu Vaccine Market Size YoY Growth 2017-2028
        6.1.2 North America Quadrivalent Flu Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Quadrivalent Flu Vaccine Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Quadrivalent Flu Vaccine Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Quadrivalent Flu Vaccine Market Size YoY Growth 2017-2028
        6.3.2 Europe Quadrivalent Flu Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Quadrivalent Flu Vaccine Market Size YoY Growth 2017-2028
        6.4.2 Latin America Quadrivalent Flu Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Quadrivalent Flu Vaccine Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Quadrivalent Flu Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Sanofi Pasteur
        7.1.1 Sanofi Pasteur Corporation Information
        7.1.2 Sanofi Pasteur Description and Business Overview
        7.1.3 Sanofi Pasteur Quadrivalent Flu Vaccine Sales, Revenue and Gross Margin (2017-2022)
        7.1.4 Sanofi Pasteur Quadrivalent Flu Vaccine Products Offered
        7.1.5 Sanofi Pasteur Recent Development
    7.2 AstraZeneca
        7.2.1 AstraZeneca Corporation Information
        7.2.2 AstraZeneca Description and Business Overview
        7.2.3 AstraZeneca Quadrivalent Flu Vaccine Sales, Revenue and Gross Margin (2017-2022)
        7.2.4 AstraZeneca Quadrivalent Flu Vaccine Products Offered
        7.2.5 AstraZeneca Recent Development
    7.3 CSL
        7.3.1 CSL Corporation Information
        7.3.2 CSL Description and Business Overview
        7.3.3 CSL Quadrivalent Flu Vaccine Sales, Revenue and Gross Margin (2017-2022)
        7.3.4 CSL Quadrivalent Flu Vaccine Products Offered
        7.3.5 CSL Recent Development
    7.4 Abbott
        7.4.1 Abbott Corporation Information
        7.4.2 Abbott Description and Business Overview
        7.4.3 Abbott Quadrivalent Flu Vaccine Sales, Revenue and Gross Margin (2017-2022)
        7.4.4 Abbott Quadrivalent Flu Vaccine Products Offered
        7.4.5 Abbott Recent Development
    7.5 GlaxoSmithKline
        7.5.1 GlaxoSmithKline Corporation Information
        7.5.2 GlaxoSmithKline Description and Business Overview
        7.5.3 GlaxoSmithKline Quadrivalent Flu Vaccine Sales, Revenue and Gross Margin (2017-2022)
        7.5.4 GlaxoSmithKline Quadrivalent Flu Vaccine Products Offered
        7.5.5 GlaxoSmithKline Recent Development
8 Industry Chain and Sales Channels Analysis
    8.1 Quadrivalent Flu Vaccine Industry Chain Analysis
    8.2 Quadrivalent Flu Vaccine Key Raw Materials
        8.2.1 Key Raw Materials
        8.2.2 Quadrivalent Flu Vaccine Distributors
    8.3 Quadrivalent Flu Vaccine Production Mode & Process
    8.4 Quadrivalent Flu Vaccine Sales and Marketing
        8.4.1 Quadrivalent Flu Vaccine Sales Channels
        8.4.2 Quadrivalent Flu Vaccine Distributors
    8.5 Quadrivalent Flu Vaccine Customers
9 Research Findings and Conclusion
10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer
List of Tables
    Table 1. Quadrivalent Flu Vaccine CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Quadrivalent Flu Vaccine Market Trends
    Table 3. Quadrivalent Flu Vaccine Market Drivers
    Table 4. Quadrivalent Flu Vaccine Market Challenges
    Table 5. Quadrivalent Flu Vaccine Market Restraints
    Table 6. Global Quadrivalent Flu Vaccine Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Quadrivalent Flu Vaccine Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Quadrivalent Flu Vaccine Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Quadrivalent Flu Vaccine Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Quadrivalent Flu Vaccine Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Quadrivalent Flu Vaccine Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Quadrivalent Flu Vaccine Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Quadrivalent Flu Vaccine Sales by Manufacturer, (K Doses), 2017-2022
    Table 14. Global Quadrivalent Flu Vaccine Sales Share by Manufacturer, 2017-2022
    Table 15. Global Quadrivalent Flu Vaccine Price by Manufacturer (2017-2022) & (USD/Dose)
    Table 16. Global Quadrivalent Flu Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Quadrivalent Flu Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Quadrivalent Flu Vaccine as of 2021)
    Table 18. Top Players of Quadrivalent Flu Vaccine in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Quadrivalent Flu Vaccine Product Type
    Table 20. Date of International Manufacturers Enter into Quadrivalent Flu Vaccine Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Quadrivalent Flu Vaccine Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Quadrivalent Flu Vaccine Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Quadrivalent Flu Vaccine Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Quadrivalent Flu Vaccine Sales by Players, (K Doses), 2020, 2021 & 2022
    Table 26. United States Quadrivalent Flu Vaccine Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Quadrivalent Flu Vaccine Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Quadrivalent Flu Vaccine Sales in Volume by Region (2017-2022) & (K Doses)
    Table 29. Global Quadrivalent Flu Vaccine Sales in Volume Forecast by Region (2023-2028) & (K Doses)
    Table 30. Global Quadrivalent Flu Vaccine Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Quadrivalent Flu Vaccine Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Quadrivalent Flu Vaccine Sales in Volume by Country (2017-2028) & (K Doses)
    Table 33. North America Quadrivalent Flu Vaccine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Quadrivalent Flu Vaccine Sales in Volume by Region (2017-2028) & (K Doses)
    Table 35. Asia Pacific Quadrivalent Flu Vaccine Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Quadrivalent Flu Vaccine Sales in Volume by Country (2017-2028) & (K Doses)
    Table 37. Europe Quadrivalent Flu Vaccine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Quadrivalent Flu Vaccine Sales in Volume by Country (2017-2028) & (K Doses)
    Table 39. Latin Americaa Quadrivalent Flu Vaccine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Quadrivalent Flu Vaccine Sales in Volume by Country (2017-2028) & (K Doses)
    Table 41. Middle East and Africa Quadrivalent Flu Vaccine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Sanofi Pasteur Corporation Information
    Table 43. Sanofi Pasteur Description and Business Overview
    Table 44. Sanofi Pasteur Quadrivalent Flu Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 45. Sanofi Pasteur Quadrivalent Flu Vaccine Product
    Table 46. Sanofi Pasteur Recent Development
    Table 47. AstraZeneca Corporation Information
    Table 48. AstraZeneca Description and Business Overview
    Table 49. AstraZeneca Quadrivalent Flu Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 50. AstraZeneca Product
    Table 51. AstraZeneca Recent Development
    Table 52. CSL Corporation Information
    Table 53. CSL Description and Business Overview
    Table 54. CSL Quadrivalent Flu Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 55. CSL Product
    Table 56. CSL Recent Development
    Table 57. Abbott Corporation Information
    Table 58. Abbott Description and Business Overview
    Table 59. Abbott Quadrivalent Flu Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 60. Abbott Product
    Table 61. Abbott Recent Development
    Table 62. GlaxoSmithKline Corporation Information
    Table 63. GlaxoSmithKline Description and Business Overview
    Table 64. GlaxoSmithKline Quadrivalent Flu Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 65. GlaxoSmithKline Product
    Table 66. GlaxoSmithKline Recent Development
    Table 67. Key Raw Materials Lists
    Table 68. Raw Materials Key Suppliers Lists
    Table 69. Quadrivalent Flu Vaccine Customers List
    Table 70. Quadrivalent Flu Vaccine Distributors List
    Table 71. Research Programs/Design for This Report
    Table 72. Key Data Information from Secondary Sources
    Table 73. Key Data Information from Primary Sources
List of Figures
    Figure 1. Quadrivalent Flu Vaccine Product Picture
    Figure 2. Global Quadrivalent Flu Vaccine Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Quadrivalent Flu Vaccine Market Size 2017-2028 (US$ Million)
    Figure 4. Global Quadrivalent Flu Vaccine Sales 2017-2028 (K Doses)
    Figure 5. United States Quadrivalent Flu Vaccine Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Quadrivalent Flu Vaccine Market Size 2017-2028 (US$ Million)
    Figure 7. United States Quadrivalent Flu Vaccine Sales 2017-2028 (K Doses)
    Figure 8. United States Quadrivalent Flu Vaccine Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Quadrivalent Flu Vaccine Market Share in Global, in Volume (K Doses) 2017-2028
    Figure 10. Quadrivalent Flu Vaccine Report Years Considered
    Figure 11. Product Picture of Intramuscular Injection
    Figure 12. Product Picture of Nasal Spray
    Figure 13. Product Picture of Intradermal Shot
    Figure 14. Global Quadrivalent Flu Vaccine Market Share by Type in 2022 & 2028
    Figure 15. Global Quadrivalent Flu Vaccine Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 16. Global Quadrivalent Flu Vaccine Sales Market Share in Value by Type (2017-2028)
    Figure 17. Global Quadrivalent Flu Vaccine Sales by Type (2017-2028) & (K Doses)
    Figure 18. Global Quadrivalent Flu Vaccine Sales Market Share in Volume by Type (2017-2028)
    Figure 19. Global Quadrivalent Flu Vaccine Price by Type (2017-2028) & (USD/Dose)
    Figure 20. United States Quadrivalent Flu Vaccine Market Share by Type in 2022 & 2028
    Figure 21. United States Quadrivalent Flu Vaccine Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 22. United States Quadrivalent Flu Vaccine Sales Market Share in Value by Type (2017-2028)
    Figure 23. United States Quadrivalent Flu Vaccine Sales by Type (2017-2028) & (K Doses)
    Figure 24. United States Quadrivalent Flu Vaccine Sales Market Share in Volume by Type (2017-2028)
    Figure 25. United States Quadrivalent Flu Vaccine Price by Type (2017-2028) & (USD/Dose)
    Figure 26. Product Picture of Hospital
    Figure 27. Product Picture of Clinic
    Figure 28. Product Picture of Public Health Agency
    Figure 29. Product Picture of Other
    Figure 30. Global Quadrivalent Flu Vaccine Market Share by Application in 2022 & 2028
    Figure 31. Global Quadrivalent Flu Vaccine Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 32. Global Quadrivalent Flu Vaccine Sales Market Share in Value by Application (2017-2028)
    Figure 33. Global Quadrivalent Flu Vaccine Sales by Application (2017-2028) & (K Doses)
    Figure 34. Global Quadrivalent Flu Vaccine Sales Market Share in Volume by Application (2017-2028)
    Figure 35. Global Quadrivalent Flu Vaccine Price by Application (2017-2028) & (USD/Dose)
    Figure 36. United States Quadrivalent Flu Vaccine Market Share by Application in 2022 & 2028
    Figure 37. United States Quadrivalent Flu Vaccine Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 38. United States Quadrivalent Flu Vaccine Sales Market Share in Value by Application (2017-2028)
    Figure 39. United States Quadrivalent Flu Vaccine Sales by Application (2017-2028) & (K Doses)
    Figure 40. United States Quadrivalent Flu Vaccine Sales Market Share in Volume by Application (2017-2028)
    Figure 41. United States Quadrivalent Flu Vaccine Price by Application (2017-2028) & (USD/Dose)
    Figure 42. North America Quadrivalent Flu Vaccine Sales in Volume Growth Rate 2017-2028 (K Doses)
    Figure 43. North America Quadrivalent Flu Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 44. U.S. Quadrivalent Flu Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Canada Quadrivalent Flu Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Europe Quadrivalent Flu Vaccine Sales in Volume Growth Rate 2017-2028 (K Doses)
    Figure 47. Europe Quadrivalent Flu Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 48. Germany Quadrivalent Flu Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. France Quadrivalent Flu Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. U.K. Quadrivalent Flu Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Italy Quadrivalent Flu Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Russia Quadrivalent Flu Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Asia-Pacific Quadrivalent Flu Vaccine Sales in Volume Growth Rate 2017-2028 (K Doses)
    Figure 54. Asia-Pacific Quadrivalent Flu Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 55. China Quadrivalent Flu Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Japan Quadrivalent Flu Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. South Korea Quadrivalent Flu Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. India Quadrivalent Flu Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Australia Quadrivalent Flu Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Taiwan Quadrivalent Flu Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Indonesia Quadrivalent Flu Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Thailand Quadrivalent Flu Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Malaysia Quadrivalent Flu Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Philippines Quadrivalent Flu Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Latin America Quadrivalent Flu Vaccine Sales in Volume Growth Rate 2017-2028 (K Doses)
    Figure 66. Latin America Quadrivalent Flu Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 67. Mexico Quadrivalent Flu Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Brazil Quadrivalent Flu Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Argentina Quadrivalent Flu Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Middle East & Africa Quadrivalent Flu Vaccine Sales in Volume Growth Rate 2017-2028 (K Doses)
    Figure 71. Middle East & Africa Quadrivalent Flu Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 72. Turkey Quadrivalent Flu Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Saudi Arabia Quadrivalent Flu Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. U.A.E Quadrivalent Flu Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 75. Quadrivalent Flu Vaccine Value Chain
    Figure 76. Quadrivalent Flu Vaccine Production Process
    Figure 77. Channels of Distribution
    Figure 78. Distributors Profiles
    Figure 79. Bottom-up and Top-down Approaches for This Report
    Figure 80. Data Triangulation
    Figure 81. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Sanofi Pasteur
AstraZeneca
CSL
Abbott
GlaxoSmithKline
Frequently Asked Questions
Quadrivalent Flu Vaccine report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Quadrivalent Flu Vaccine report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Quadrivalent Flu Vaccine report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Rhum Agricole

Rhum Agricole market is segmented by region (country), players, by Type and by Application. Playe ... Read More